Insider Transactions in Q3 2022 at Oncternal Therapeutics, Inc. (ONCT)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 28
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,125
+24.73%
|
-
|
|
Jul 28
2022
|
Salim Yazji Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+35.54%
|
-
|
|
Jul 28
2022
|
Chase C. Leavitt General Counsel/Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
43,125
+32.89%
|
-
|
|
Jul 28
2022
|
Rajesh Krishnan CTO/CSO |
BUY
Grant, award, or other acquisition
|
Direct |
43,125
+37.14%
|
-
|
|
Jul 28
2022
|
Gunnar F. Kaufmann Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,125
+37.14%
|
-
|
|
Jul 28
2022
|
James B Breitmeyer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
18,750
+42.62%
|
-
|
|
Jul 28
2022
|
James B Breitmeyer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,625
+24.57%
|
-
|